We use cookies to help provide you with the best possible online experience. By using this site, you agree that we may store and access cookies on your device. You can find out more about how to set your own preferences here.

Calcium Mefolinate

Active Pharmaceutical Ingredient, (6RS)-N5-Methyl-tetrahydrofolic Acid Calcium Salt (5-MeTHF), is suitable for oncological and nutritional use. Can also be subscribed for treatment of depressive disorders.

A characteristic property which distinguishes N5-Methyl-tetrahydrofolic Acid Calcium Salt from other Reduced Folates is that it can cross the brain blood barrier. This has significance for example, in cases of treatment for depression. It is also subscribed for both oncological and nutritional use as other Reduced Folates.

USE

5-Methyl-tetrahydrofolic Acid Calcium Salt (5-MeTHF) is prescribed for anemic indications. In particular, it is recommended in cases of Folate deficiencies, especially for the health of the elderly, children and women. For anemic symptoms Oral Dosage Forms are usually administered.

For more details on the use of 5-Methyl-Tetrahydrofolic Acid in the oncological and nutritional field, see Reduced Folates chapter.

A characteristic property which distinguishes 5-Methyl-Tetrahydrofolic Acid from other reduced folates is that it can cross the brain blood barrier. This has implications, for example, in cases of treatment for depression as shown in the chapter on general Reduced Folates.